Investor Due Diligence and Legitimate Expectations
نویسندگان
چکیده
Abstract This article examines the significance of investor due diligence in context a claim that host State has breached its obligation to provide fair and equitable treatment (FET). Despite increasing reliance on exercises, there are considerable differences how tribunals understand use such exercises. These related different visions function future international investment law. After exploring approaches taken, this will argue most coherent approach is treat as merely technique for assessing reasonableness prudence, rather than strict requirement.
منابع مشابه
Modelling Legitimate Expectations
Legitimate expectation in the context of culpa in contrahendo is an important legal concept for the study of good faith and the duty to negotiate with good care. However when wanting to model it and reason about it, one finds that most existing legal formalisations do not directly account for the concept. In this paper we present a formal model that can explicitly model and reason about legitim...
متن کاملDue Diligence in Transactions Involving Intellectual Property
The process of gathering information and assessing the merits, issues, and risks associated with a business transaction is called “due diligence,” which is a critical analysis in the acquisition and strategic utilization of intellectual property (IP) assets. Due diligence is a necessary precursor to funding a new venture, and it is critically important in many other business transactions, inclu...
متن کاملSix Questions About Translational Due Diligence
C R E D IT : L . C O U RT N E Y /R O C H E ST E R IN ST IT U TE O F TE C H N O LO G Y SECURING SUSTAINABLE RESPECT AND SUPPORT Ensuring that translational research is respected and supported over the long run requires more than the conversion of basic research into technologies that professionals can use to improve medical outcomes and the reverse translation of fi ndings from clinic to bench. ...
متن کاملThe Importance of CRISPR-9 Due Diligence
On February 15, 2017, the United States Patent and Trademark Office’s Patent Trial and Appeal Board announced its long-awaited decision finding no interference-in-fact between patents and patent applications directed to CRISPR-Cas9 owned by Broad Institute, Inc. et al. and patent applications owned by Regents of the University of California et al. The decision found that the CRISPR-Cas9 gene-ed...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The journal of world investment & trade
سال: 2022
ISSN: ['1660-7112', '2211-9000']
DOI: https://doi.org/10.1163/22119000-12340231